Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $611.83 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $317.07 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $188.42 | 2 | $0 (2018) |
| Gilead Sciences, Inc. | $106.34 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $222.56 | 2 | Genentech USA, Inc. ($116.22) |
| 2018 | $264.54 | 3 | AstraZeneca Pharmaceuticals LP ($188.42) |
| 2017 | $124.73 | 1 | Genentech USA, Inc. ($124.73) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $116.22 | General |
| 11/14/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $106.34 | General |
| Category: HBV | ||||||
| 12/13/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $108.99 | General |
| 11/29/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $76.12 | General |
| 10/25/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $79.43 | General |
| 11/30/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $124.73 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 25 | $6,325 | $587.70 |
| 2022 | 1 | 13 | 24 | $6,058 | $813.04 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 16 | 25 | $6,325 | $587.70 | 9.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 13 | 24 | $6,058 | $813.04 | 13.4% |
About Dr. Qi-Lin Cheng, MD
Dr. Qi-Lin Cheng, MD is a Anatomic Pathology healthcare provider based in Walnut Creek, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346312188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Qi-Lin Cheng, MD has received a total of $611.83 in payments from pharmaceutical and medical device companies, with $222.56 received in 2019. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($611.83).
As a Medicare-enrolled provider, Cheng has provided services to 29 Medicare beneficiaries, totaling 49 services with total Medicare billing of $1,401. Data is available for 2 years (2022–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location Walnut Creek, CA
- Active Since 11/15/2006
- Last Updated 01/10/2022
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1346312188
Products in Payments
- Vemlidy (Drug) $106.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Walnut Creek
Cui Chen, Md, MD
Anatomic Pathology — Payments: $505.49
John Walsh, Md, MD
Anatomic Pathology — Payments: $399.85
Lynne Brewer, Md, MD
Anatomic Pathology — Payments: $124.19
David Forth, Md, MD
Anatomic Pathology
Teresa Steinkirchneranderson, Md, MD
Anatomic Pathology
Jody Burkes, Md, MD
Anatomic Pathology